Use of lipid‐lowering therapies in patients with chronic kidney disease and atherosclerotic cardiovascular disease: 2‐year results from G etting to an impr O ved U nderstanding of... by Shaik, Aleesha, Kosiborod, Mikhail, de Lemos, James A., Gao, Qi, Mues, Katherine E., Alam, Shushama, Bhatt, Deepak L., Cannon, Christopher P., Ballantyne, Christie M., Rosenson, Robert S.

Get full text

Targeting dyslipidemia—the key to CHD risk reduction in the diabetic population? by Betteridge, D. John, Rosenson, Robert S.

Get full text

Abstract 9121: Lipoprotein(a) and the Risk for Coronary Heart Disease and Ischemic Stroke Events Among Black and White Adults with Cardiovascular Disease by Colantonio, Lisandro D, Bittner, Vera A, Safford, Monika M, Marcovina, Santica M, Brown, Todd M, Jackson, Elizabeth A, Li, Mei, Lopez, J. Antonio G, Monda, Keri L, Plante, Tim B, Kent, Shia, Muntner, Paul, Rosenson, Robert S

Get full text

ACCF/ACR/AHA/NASCI/SCMR 2010 expert consensus document on cardiovascular magnetic resonance: a report of the American College of Cardiology Foundation Task Force on Expert Consensu... by Hundley, W Gregory, Bluemke, David A, Finn, J Paul, Flamm, Scott D, Fogel, Mark A, Friedrich, Matthias G, Ho, Vincent B, Jerosch-Herold, Michael, Kramer, Christopher M, Manning, Warren J, Patel, Manesh, Pohost, Gerald M, Stillman, Arthur E, White, Richard D, Woodard, Pamela K

Get full text

Translating HDL Science to Clinical Practice by Barter, Philip J., MD, PhD, Chapman, M. John, BS, PhD, DSc, Rader, Daniel J., MD, FNLA, Rosenson, Robert S., MD, FNLA, Schaefer, Ernst J., MD, FNLA

Get full text

2012 American College of Cardiology Foundation/ Society for Cardiovascular Angiography and Interventions Expert Consensus Document on Cardiac Catheterization Laboratory Standards U... by BASHORE, Thomas M

Get full text

Improvements in Lipid Ratios with the Combination of Rosuvastatin 5 mg and Fenofibric Acid 135 mg in Patients with Mixed Dyslipidemia by Rosenson, Robert S., MD, Kelly, Maureen T, Setze, Carolyn M, Gold, Alex, Cressman, Michael, Stolzenbach, James C, Williams, Laura A

Get full text

Simultaneous Achievement of Optimal Lipid Targets with the Combination of Rosuvastatin 5 mg + Fenofibric Acid 135 mg in Patients with Mixed Dyslipidemia by Rosenson, Robert S., MD, Kelly, Maureen T, Setze, Carolyn M, Gold, Alex, Cressman, Michael, Stolzenbach, James C, Williams, Laura A

Get full text

Lp-PLA^sub 2^ and risk of atherosclerotic vascular disease by Rosenson, Robert S

Get full text

ACCF/ACR/AHA/NASCI/SAIP/SCAI/SCCT 2010 expert consensus document on coronary computed tomographic angiography: a report of the American College of Cardiology Foundation Task Force... by Mark, Daniel B, Berman, Daniel S, Budoff, Matthew J, Carr, J Jeffrey, Gerber, Thomas C, Hecht, Harvey S, Hlatky, Mark A, Hodgson, John McB, Lauer, Michael S, Miller, Julie M, Morin, Richard L, Mukherjee, Debabrata, Poon, Michael, Rubin, Geoffrey D, Schwartz, Robert S

Get full text

Evinacumab Reduces US Apheresis Eligibility in Patients with Homozygous Familial Hypercholesterolemia by Raal, Fredrick J, McGinniss, Jennifer, Pordy, Robert, Georga, Richard T, Banerjee, Poulabi, Zhai, Jian, Ali, Shazia, Moriarty, Patrick M, Rosenson, Robert S

Get full text

CHALLENGES IN CHOLESTEROL MANAGEMENT IN PATIENTS WITH ATHEROSCLEROTIC CARDIOVASCULAR DISEASE: INSIGHTS FROM PATIENT AND PHYSICIAN SURVEYS IN THE GOULD STUDY by Arnold, Suzanne, de Lemos, James, Bhatt, Deepak, Liu, Yuyin, Rosenson, Robert S., Ballantyne, Christie M., Mues, Katherine, Alam, Shushama, Cannon, Christopher P., Kosiborod, Mikhail

Get full text

INTENSITY OF LIPID LOWERING THERAPY AND LDL-C LEVELS AFTER 12 MONTHS IN PATIENTS WITH POLYVASCULAR DISEASE—INSIGHTS FROM THE GOULD REGISTRY by Peterson, Ben, Bhatt, Deepak, Ballantyne, Christie M., de Lemos, James, Rosenson, Robert S., Mues, Katherine, Elliott-Davey, Mary, Alam, Shushama, Liu, Yuyin, Kosiborod, Mikhail, Cannon, Christopher P.

Get full text

ABCA1 Deficiency by Malick, Waqas A., Schaefer, Ernst J., Hegele, Robert A., Rosenson, Robert S.

Get full text

Reply by Rosenson, Robert S, Farkouh, Michael E, Muntner, Paul

Get full text

Reply by Rosenson, Robert S., Farkouh, Michael E., Muntner, Paul

Get full text

Lp-PLA 2 and risk of atherosclerotic vascular disease by Rosenson, Robert S

Get full text

ACCF/ACG/AHA 2008 Expert Consensus Document on Reducing the Gastrointestinal Risks of Antiplatelet Therapy and NSAID Use by Bhatt, Deepak L., MD, FACC, FAHA, Scheiman, James, MD, FACG, Abraham, Neena S., MD, MSCE, FACG, Antman, Elliott M., MD, FACC, FAHA, Chan, Francis K.L., MD, FACG, Furberg, Curt D., MD, FAHA, Johnson, David A., MD, FACG, Mahaffey, Kenneth W., MD, FACC, Quigley, Eamonn M., MD, FACG, Harrington, Robert A., MD, FACC, Bates, Eric R., MD, FACC, Bridges, Charles R., MD, MPH, FACC, Eisenberg, Mark J., MD, MPH, FACC, Ferrari, Victor A., MD, FACC, Hlatky, Mark A., MD, FACC, Kaul, Sanjay, MBBS, FACC, Lindner, Jonathan R., MD, FACC, Moliterno, David J., MD, FACC, Mukherjee, Debabrata, MD, FACC, Schofield, Richard S., MD, FACC, Rosenson, Robert S., MD, FACC, Stein, James H., MD, FACC, Weitz, Howard H., MD, FACC, Wesley, Deborah J., RN, BSN

Get full text

Abstract 14267: Evinacumab Lowers LDL-C in Patients With Homozygous Familial Hypercholesterolemia Irrespective of Background Lipid-lowering Medication by Raal, Frederick J, Rosenson, Robert S, Reeskamp, Laurens F, Hovingh, G. Kees, Kastelein, John J, Rubba, Paolo, Ali, Shazia, Banerjee, Poulabi, Chan, Kuo-Chen, Khilla, Nagwa, McGinniss, Jennifer, Pordy, Robert, Zhang, Yi, Gaudet, Daniel

Get full text

Abstract 14407: The Longer-term Efficacy and Safety of Evinacumab in Patients With Homozygous Familial Hypercholesterolemia by Raal, Frederick J, Rosenson, Robert S, Reeskamp, Laurens F, Hovingh, G. Kees, Kastelein, John J, Rubba, Paolo, Ali, Shazia, Banerjee, Poulabi, Chan, Kuo-Chen, Khilla, Nagwa, Pordy, Robert, Zhang, Yi, Gaudet, Daniel

Get full text